-
1
-
-
84901731129
-
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
-
PID: 24803231
-
Mori S, Koga Y. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Clin Rheumatol. 2014. doi:10.1007/s10067-014-2650-y.
-
(2014)
Clin Rheumatol
-
-
Mori, S.1
Koga, Y.2
-
2
-
-
0031243064
-
Prevalence of synovitis in patients with polymyalgia rheumatica and/or giant cell arteritis
-
COI: 1:STN:280:DyaK1c%2Fks1yisQ%3D%3D, PID: 9385703
-
Devauchelle V, Saraux A, Youinou P, Le Goff P. Prevalence of synovitis in patients with polymyalgia rheumatica and/or giant cell arteritis. Rev Rhum Engl Ed. 1997;64:594–5.
-
(1997)
Rev Rhum Engl Ed
, vol.64
, pp. 594-595
-
-
Devauchelle, V.1
Saraux, A.2
Youinou, P.3
Le Goff, P.4
-
3
-
-
0020374840
-
Polymyalgia rheumatica: a 10 years epidemiologic and clinical study
-
COI: 1:STN:280:DyaL3s%2Fks1KitQ%3D%3D, PID: 6982645
-
Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10 years epidemiologic and clinical study. Ann Intern Med. 1982;97:672–80.
-
(1982)
Ann Intern Med
, vol.97
, pp. 672-680
-
-
Chuang, T.Y.1
Hunder, G.G.2
Ilstrup, D.M.3
Kurland, L.T.4
-
4
-
-
34248375722
-
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial
-
PID: 17470831
-
Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med. 2007;146:631–9.
-
(2007)
Ann Intern Med
, vol.146
, pp. 631-639
-
-
Salvarani, C.1
Macchioni, P.2
Manzini, C.3
Paolazzi, G.4
Trotta, A.5
Manganelli, P.6
-
5
-
-
34248351219
-
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial
-
PID: 17470830
-
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146:621–30.
-
(2007)
Ann Intern Med
, vol.146
, pp. 621-630
-
-
Hoffman, G.S.1
Cid, M.C.2
Rendt-Zagar, K.E.3
Merkel, P.A.4
Weyand, C.M.5
Stone, J.H.6
-
6
-
-
70449638401
-
Treatment of polymyalgia rheumatica: a systematic review
-
COI: 1:CAS:528:DC%2BD1MXhsVyqsbjF, PID: 19901135
-
Hernandez-Rodriguez J, Cid MC, Lopez-Soto A, Espigol-Frigole G, Bosch X. Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med. 2009;169:1839–50.
-
(2009)
Arch Intern Med
, vol.169
, pp. 1839-1850
-
-
Hernandez-Rodriguez, J.1
Cid, M.C.2
Lopez-Soto, A.3
Espigol-Frigole, G.4
Bosch, X.5
-
7
-
-
42749092917
-
Epidemiology, imaging, and treatment of giant cell arteritis
-
PID: 18378179
-
Devauchelle-Pensec V, Jousse S, Destombe C, Saraux A. Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine. 2008;75(3):267–72.
-
(2008)
Joint Bone Spine
, vol.75
, Issue.3
, pp. 267-272
-
-
Devauchelle-Pensec, V.1
Jousse, S.2
Destombe, C.3
Saraux, A.4
-
8
-
-
5344221586
-
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial
-
COI: 1:CAS:528:DC%2BD2cXptFOhtb4%3D, PID: 15466766
-
Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004;141:493–500.
-
(2004)
Ann Intern Med
, vol.141
, pp. 493-500
-
-
Caporali, R.1
Cimmino, M.A.2
Ferraccioli, G.3
Gerli, R.4
Klersy, C.5
Salvarani, C.6
-
9
-
-
73449087360
-
Circulating cytokines in active polymyalgia rheumatica
-
COI: 1:CAS:528:DC%2BC3cXhtFOlsLY%3D, PID: 19254903
-
Alvarez-Rodriguez L, Lopez-Hoyos M, Mata C, Marin MJ, Calvo-Alen J, Blanco R, et al. Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis. 2010;69:263–9.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 263-269
-
-
Alvarez-Rodriguez, L.1
Lopez-Hoyos, M.2
Mata, C.3
Marin, M.J.4
Calvo-Alen, J.5
Blanco, R.6
-
10
-
-
77951783966
-
Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica
-
PID: 20439532
-
Hagihara K, Kawase I, Tanaka T, Kishimoto T. Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica. J Rheumatol. 2010;37:1075–6.
-
(2010)
J Rheumatol
, vol.37
, pp. 1075-1076
-
-
Hagihara, K.1
Kawase, I.2
Tanaka, T.3
Kishimoto, T.4
-
11
-
-
84901911156
-
Tocilizumab in refractory aortitis: study on 16 patients and literature review
-
PID: 24854377
-
Loricera J, Blanco R, Castaneda S, Humbría A, Ortego-Centeno N, Narváez J, et al. Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S79–89.
-
(2014)
Clin Exp Rheumatol
, vol.32
, pp. 79-89
-
-
Loricera, J.1
Blanco, R.2
Castaneda, S.3
Humbría, A.4
Ortego-Centeno, N.5
Narváez, J.6
-
12
-
-
4644236004
-
A disease activity score for polymyalgia rheumatica
-
COI: 1:STN:280:DC%2BD2cvlt1aisQ%3D%3D, PID: 15361387
-
Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis. 2004;63:1279–83.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1279-1283
-
-
Leeb, B.F.1
Bird, H.A.2
-
13
-
-
84856530490
-
Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice
-
COI: 1:CAS:528:DC%2BC38XksVejtbk%3D, PID: 22174199
-
Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol. 2012;39:310–3.
-
(2012)
J Rheumatol
, vol.39
, pp. 310-313
-
-
Cleuziou, C.1
Binard, A.2
De Bandt, M.3
Berthelot, J.M.4
Saraux, A.5
-
14
-
-
84907202542
-
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
-
PID: 25113771
-
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.
-
(2014)
J Clin Oncol
, vol.32
, pp. 3048-3058
-
-
Barrington, S.F.1
Mikhaeel, N.G.2
Kostakoglu, L.3
Meignan, M.4
Hutchings, M.5
Müeller, S.P.6
-
15
-
-
33746539507
-
Monitoring chemotherapy and radiotherapy of solid tumors
-
PID: 16688451
-
Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33:27–37.
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 27-37
-
-
Weber, W.A.1
Wieder, H.2
-
16
-
-
84868198334
-
FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis
-
PID: 22820649
-
Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39:1538–44.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 1538-1544
-
-
Nanni, C.1
Boriani, L.2
Salvadori, C.3
Zamparini, E.4
Rorato, G.5
Ambrosini, V.6
-
17
-
-
84908490941
-
Utility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis
-
PID: 25378838
-
Guleria R, Jyothidasan A, Madan K, Mohan A, Kumar R, Bhalla AS, et al. Utility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis. Lung India. 2014;31:323–30.
-
(2014)
Lung India
, vol.31
, pp. 323-330
-
-
Guleria, R.1
Jyothidasan, A.2
Madan, K.3
Mohan, A.4
Kumar, R.5
Bhalla, A.S.6
-
18
-
-
84906822471
-
Clinical value of whole-body PET/CT in patients with active rheumatic diseases
-
PID: 25606590
-
Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Ther. 2014;16:423.
-
(2014)
Arthritis Res Ther
, vol.16
, pp. 423
-
-
Yamashita, H.1
Kubota, K.2
Mimori, A.3
-
19
-
-
0033982778
-
Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch
-
COI: 1:STN:280:DC%2BD3c7os1Ghuw%3D%3D, PID: 10723979
-
Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.
-
(2000)
Am J Med
, vol.108
, pp. 246-249
-
-
Blockmans, D.1
Stroobants, S.2
Maes, A.3
Mortelmans, L.4
-
20
-
-
34047118153
-
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
-
COI: 1:STN:280:DC%2BD2s7nvFSrtw%3D%3D
-
Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford). 2007;46:672–7.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 672-677
-
-
Blockmans, D.1
De Ceuninck, L.2
Vanderschueren, S.3
Knockaert, D.4
Mortelmans, L.5
Bobbaers, H.6
-
21
-
-
79960122988
-
FDG-PET/CT of polymyalgia rheumatica
-
PID: 21153039
-
Kotani T, Komori T, Kanzaki Y, Takeuchi T, Wakura D, Iimori A, et al. FDG-PET/CT of polymyalgia rheumatica. Mod Rheumatol. 2011;21:334–6.
-
(2011)
Mod Rheumatol
, vol.21
, pp. 334-336
-
-
Kotani, T.1
Komori, T.2
Kanzaki, Y.3
Takeuchi, T.4
Wakura, D.5
Iimori, A.6
-
22
-
-
84875515028
-
Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis
-
PID: 22749663
-
Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, et al. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine. 2013;80:171–7.
-
(2013)
Joint Bone Spine
, vol.80
, pp. 171-177
-
-
Yamashita, H.1
Kubota, K.2
Takahashi, Y.3
Minamimoto, R.4
Morooka, M.5
Kaneko, H.6
-
23
-
-
84870368569
-
Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis
-
PID: 22205118
-
Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol. 2012;22:705–11.
-
(2012)
Mod Rheumatol
, vol.22
, pp. 705-711
-
-
Yamashita, H.1
Kubota, K.2
Takahashi, Y.3
Minaminoto, R.4
Morooka, M.5
Ito, K.6
-
24
-
-
67849116850
-
F-18 FDG PET/CT of polymyalgia rheumatica
-
PID: 19387211
-
Toriihara A, Seto Y, Yoshida K, Umehara I, Nakagawa T, Liu R, et al. F-18 FDG PET/CT of polymyalgia rheumatica. Clin Nucl Med. 2009;34:305–6.
-
(2009)
Clin Nucl Med
, vol.34
, pp. 305-306
-
-
Toriihara, A.1
Seto, Y.2
Yoshida, K.3
Umehara, I.4
Nakagawa, T.5
Liu, R.6
-
25
-
-
80455164741
-
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis
-
PID: 21559981
-
Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S, Bouvard G, et al. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1764-1772
-
-
Besson, F.L.1
Parienti, J.J.2
Bienvenu, B.3
Prior, J.O.4
Costo, S.5
Bouvard, G.6
-
27
-
-
84881542249
-
Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature
-
COI: 1:CAS:528:DC%2BC3sXivFyisbY%3D, PID: 23433960
-
Macchioni P, Boiardi L, Catanoso M, Pulsatelli L, Pipitone N, Meliconi R, et al. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum. 2013;43:113–8.
-
(2013)
Semin Arthritis Rheum
, vol.43
, pp. 113-118
-
-
Macchioni, P.1
Boiardi, L.2
Catanoso, M.3
Pulsatelli, L.4
Pipitone, N.5
Meliconi, R.6
-
28
-
-
84865182162
-
The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT
-
COI: 1:CAS:528:DC%2BC38XhtFagu7nN
-
Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford). 2012;51:1484–91.
-
(2012)
Rheumatology (Oxford)
, vol.51
, pp. 1484-1491
-
-
Okamura, K.1
Yonemoto, Y.2
Arisaka, Y.3
Takeuchi, K.4
Kobayashi, T.5
Oriuchi, N.6
-
29
-
-
54949135724
-
An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis
-
COI: 1:STN:280:DC%2BD1cnkvFeltg%3D%3D, PID: 18821687
-
Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–67.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2958-2967
-
-
Brown, A.K.1
Conaghan, P.G.2
Karim, Z.3
Quinn, M.A.4
Ikeda, K.5
Peterfy, C.G.6
-
30
-
-
60149109335
-
Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans
-
COI: 1:CAS:528:DC%2BD1MXjvFOht7w%3D, PID: 19076727
-
Kanstrup IL, Klausen TL, Bojsen-Møller J, Magnusson P, Zerahn B. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans. Clin Physiol Funct Imaging. 2009;29(2):108–13.
-
(2009)
Clin Physiol Funct Imaging
, vol.29
, Issue.2
, pp. 108-113
-
-
Kanstrup, I.L.1
Klausen, T.L.2
Bojsen-Møller, J.3
Magnusson, P.4
Zerahn, B.5
|